A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Name: A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
License: Public Domain

First Affiliated Hospital of Wenzhou Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

locally advanced rectal cancer (larc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 471465
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.